BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 30232106)

  • 41. Compliance with breast and cervical cancer screening programs in women: results from a population-based study.
    Berardi R; Nacciarriti D; Tamburrano T; Carbonari G; Romagnoli E; Duca M; Burattini M; Silva RR; Cellerino R; Cascinu S;
    Tumori; 2013; 99(5):565-71. PubMed ID: 24362858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Who has Pap tests? Variables associated with the use of Pap tests in absence of screening programmes.
    Ronco G; Segnan N; Ponti A
    Int J Epidemiol; 1991 Jun; 20(2):349-53. PubMed ID: 1917233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differences in breast and cervical cancer screening between West and East Germany: a secondary analysis of a german nationwide health survey.
    Großmann LM; Napierala H; Herrmann WJ
    BMC Public Health; 2023 Oct; 23(1):1931. PubMed ID: 37798695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
    Guo F; Hirth JM; Berenson AB
    J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temporal trend in socioeconomic inequalities in the uptake of cancer screening programmes in France between 2005 and 2010: results from the Cancer Barometer surveys.
    Kelly DM; Estaquio C; Léon C; Arwidson P; Nabi H
    BMJ Open; 2017 Dec; 7(12):e016941. PubMed ID: 29247085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
    Nuño T; Castle PE; Harris R; Estrada A; García F;
    J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast and cervical cancer screening in obese minority women.
    Ferrante JM; Chen PH; Jacobs A
    J Womens Health (Larchmt); 2006 Jun; 15(5):531-41. PubMed ID: 16796480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening mammography and Pap tests among older American women 1996-2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD).
    Ostbye T; Greenberg GN; Taylor DH; Lee AM
    Ann Fam Med; 2003; 1(4):209-17. PubMed ID: 15055410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Social disparities in access to breast and cervical cancer screening by women living in Spain.
    Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
    Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Demographic predictors of mammography and Pap smear screening in US women.
    Calle EE; Flanders WD; Thun MJ; Martin LM
    Am J Public Health; 1993 Jan; 83(1):53-60. PubMed ID: 8417607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Breast and cervical cancer screening: knowledge, attitudes and behavior among schoolteachers in Italy.
    Pavia M; Ricciardi G; Bianco A; Pantisano P; Langiano E; Angelillo IF
    Eur J Epidemiol; 1999 Apr; 15(4):307-11. PubMed ID: 10414369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inequity of healthcare utilization on mammography examination and Pap smear screening in Thailand: Analysis of a population-based household survey.
    Chongthawonsatid S
    PLoS One; 2017; 12(3):e0173656. PubMed ID: 28282430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pap Testing in a High-Income Country with Suboptimal Compliance Levels: A Survey on Acceptance Factors among Sicilian Women.
    Restivo V; Costantino C; Marras A; Napoli G; Scelfo S; Scuderi T; Casuccio A; Cernigliaro A; Giusti A; Spila Alegiani S
    Int J Environ Res Public Health; 2018 Aug; 15(9):. PubMed ID: 30131461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey.
    Watson M; Benard V; King J; Crawford A; Saraiya M
    Prev Med; 2017 Jul; 100():243-247. PubMed ID: 28502575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Access to Personal Health Records and Screening for Breast and Cervical Cancer Among Women with a Family History of Cancer.
    Kim H; Mahmood A; Carlton E; Goldsmith J; Chang C; Bhuyan S
    J Cancer Educ; 2020 Dec; 35(6):1128-1134. PubMed ID: 31264113
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design and evaluation of a theory-based, culturally relevant outreach model for breast and cervical cancer screening for Latina immigrants.
    White K; Garces IC; Bandura L; McGuire AA; Scarinci IC
    Ethn Dis; 2012; 22(3):274-80. PubMed ID: 22870569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mammography screening in Italy: 2005 survey and 2006 preliminary data.
    Giorgi D; Giordano L; Ventura L; Frigerio A; Paci E; Zappa M
    Epidemiol Prev; 2008; 32(2 Suppl 1):7-22. PubMed ID: 18770992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Women with Visual Impairment and Insured by Medicaid or Medicare Are Less Likely to Receive Recommended Screening for Breast and Cervical Cancers.
    Xu X; Mann JR; McDermott SW; Deroche CB; Gustafson E; Hardin JW
    Ophthalmic Epidemiol; 2017 Jun; 24(3):168-173. PubMed ID: 27552166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Smoking and cancer screening for women ages 42-75: associations in the 1990-1994 National Health Interview Surveys.
    Rakowski W; Clark MA; Ehrich B
    Prev Med; 1999 Dec; 29(6 Pt 1):487-95. PubMed ID: 10600429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.